Endoscopic retrograde cholangiopancreatography and laparoscopic cholecystectomy during the same session: Feasibility and safety

Table 1 Characteristics of the patients

Characteristic	Group 1 (n = 91)	Group 2 (n = 65)
Age (yr)	53.6 ± 8.7	55.3 ± 9.4
Sex (male/female)	32/59	17/48
ASA (I/II/III)	63/23/5	12/4/1949
Diameter of CBD (mm)	10.5 ± 2.6	11.2 ± 2.7
Maximal diameter of CBD stone (mm)	6.4 ± 1.4	6.7 ± 1.3
Bilirubin (μmol/L)	37.3 ± 8.6	39.1 ± 9.2
Alanine aminotransferase (U/L)	127.2 ± 43.5	119.5 ± 47.8
Aspartate aminotransferase (U/L)	105.9 ± 32.7	109.8 ± 35.0
Gamma glutamyl transpeptidase (U/L)	224.3 ± 63.3	233.1 ± 65.1

CBD: Common bile duct; ASA: American Society of Anesthesiologists.

Table 2 Outcomes of endoscopic procedures, laparoscopic cholecystectomy

	Group 1 (n = 91)	Group 2 (n = 65)
Endoscopic procedures
Success rate	97.80%	98.50%
Time (min)	34.9 ± 10.9	35.3 ± 9.7
Complications	4.40%	4.62%
Pancreatitis (n)	2	2
Hemorrhage (n)	1	1
Cholangitis (n)	1	0
Nasobiliary drainage (n)	11	8
CBD stone clearance	96.70%	96.90%
Laparoscopic cholecystectomy
Operation duration (min)	53.6 ± 12.1	52.8 ± 13.4
Subhepatic drainage (n)	6	5
Time to flatus (h)	17.5 ± 6.7	18.3 ± 7.1
Complications (n)
Infection	1	1
Bleeding	1	0
Conversion	1	1
Hospital stay (d)
Postoperative	3.13 ± 0.96	2.95 ± 1.08
Total (P < 0.01)	5.32 ± 1.26	9.27 ± 1.31

CBD: Common bile duct.